NGN Capital has led a €33m series-D round in NOXXON Pharma. NGN is a new investor and was joined by existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow Venture Capital, FCP OP MEDICAL BioHealth-Trends, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the Dieckell Group, and others.
The GP said it will pursue a buy-and-build strategy in the life science IT services sector
Dominic Schmidt is based in the UK, while Satish Jindal and Katrine Bosley join in the US
Five Arrows has owned a majority stake in the France-based low-cost pharmacy chain since 2016
Hg acquired the software platform for care providers in 2018 from ECM Equity Capital Management